Solvent recovery takes sting out of carbon tax

Grab the CFO and sharpen a pencil. The carbon dioxide tax is coming, and pharma manufacturers need to do something about it.

Drugmakers, of course, are among the biggest industrial consumers of solvents. So they stand to be among those hardest hit by the tax. But solvent recovery may help soften the blow, providing profit protection in the short run and getting processes on track for the inevitable lower emissions future.

To develop a CO2-tax action plan, figure out the impact of the tax on your operation, says Rockwell Automation in Sustainable Plant magazine. Cap-and-trade legislation is likely to yield a tax of $28 per ton.

Then compare an investment analysis of recovery versus incineration, with and without a carbon tax. Rockwell calculates a case where the carbon tax doubles the solvent recovery investment return while posing only moderate or lower-level risk.

- here's the case
- read more from Sustainable Plant (.pdf)

Relted Articles:
Recycle solvents for big emissions cut
AZ works to reduce energy, solvent use
Pfizer, Rowan pursue solvent recovery

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.